Bioconjugates/ADC

Elisabeth Engelsberger, Ph.D.

Elisabeth Engelsberger is currently an Associate Principal Chemist in Bioconjugate Early Development at Lonza`s site in Visp. She consults customers in the design of bioconjugates, leads projects focused on early development, supports technology screening and establishment of external collaborations. She studied chemistry at the Technical University of Munich, the Philipps-University Marburg and Imperial College London. She earned her PhD at ETH Zürich in organic chemistry.

Content by this expert

Recently published by Elisabeth

Article

Accelerate and De-Risk Bioconjugate Drug Development with the Lonza Bioconjugation Toolbox

We follow an ‘Innovation through collaboration’ approach and aim to facilitate access to...